Clinical Trial Update: Umbilical Cord Derived Mesenchymal Stem Cells Treatment in Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating umbilical cord-derived mesenchymal stem cells for ischemic stroke; current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Umbilical cord-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Affiliated Hospital to Academy of Military Medical Sciences | Conditions: Stroke | Phase 2 | Status: UNKNOWN